Gluconorm G2 Tablet PR is a combination oral antidiabetic medication containing Glimepiride 2mg and Metformin 500mg, formulated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, enhances pancreatic beta-cell insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily decreases hepatic glucose production and improves peripheral insulin sensitivity, contributing to better glycemic control. The combination of these two agents offers complementary mechanisms of action, providing effective control of hyperglycemia in patients inadequately managed by diet and exercise alone. Gluconorm G2 Tablet PR is designed as a prolonged-release formulation to ensure sustained plasma drug levels, improving patient compliance and minimizing gastrointestinal side effects commonly associated with immediate-release metformin. It is indicated for adult patients with type 2 diabetes mellitus who require dual therapy to achieve target glycemic levels. The medication should be used alongside lifestyle modifications including diet and exercise. Caution is advised in patients with renal or hepatic impairment, and regular monitoring of blood glucose and renal function is recommended. Hypoglycemia risk is present due to glimepiride, necessitating patient education on symptom recognition and management.